Suppr超能文献

组织因子和组织因子途径抑制剂在溃疡性结肠炎中的表达的临床意义

Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis.

作者信息

He Hao-Lan, Zhang Ji-Bin, Li Qian

机构信息

Hao-Lan He, Qian Li, Department of Gastroenterology, Central Hospital Affiliated to Shenyang Medical College, Shenyang 110024, Liaoning Province, China.

出版信息

World J Gastroenterol. 2014 Jun 21;20(23):7461. doi: 10.3748/wjg.v20.i23.7461.

Abstract

AIM

To investigate the clinical significance of expression of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in ulcerative colitis (UC).

METHODS

Thirty UC specimens taken by colonoscopy from patients with active UC treated at the Department of Pathology, Central Hospital Affiliated to Shenyang Medical College from February 2010 to January 2012 were included in an experimental group, and 30 normal colon tissue samples taken by colonoscopy from non-UC patients were included in a control group. Expression of TF and TFPI in UC and normal colon tissue samples was detected by immunohistochemistry.

RESULTS

The positive rate of TF in UC was significantly higher than that in normal colon tissue (63% vs 33%, χ(2) = 5.41, P < 0.05). The positive rate of TFPI in UC was also significantly higher than that in normal colon tissue (43% vs 17%, χ(2) = 5.08, P < 0.05).

CONCLUSION

Positive rates of TF and TFPI expression in UC are significantly higher than those in normal colon tissue. TF and TFPI may play an important role in the pathogenesis of UC.

摘要

目的

探讨组织因子(TF)和组织因子途径抑制物(TFPI)在溃疡性结肠炎(UC)中的表达及其临床意义。

方法

选取2010年2月至2012年1月在沈阳医学院附属中心医院病理科接受治疗的30例活动期UC患者的结肠镜检查标本作为实验组,另选取30例非UC患者的结肠镜检查正常结肠组织标本作为对照组。采用免疫组织化学法检测UC组织和正常结肠组织中TF和TFPI的表达。

结果

UC组织中TF的阳性率显著高于正常结肠组织(63% 对33%,χ(2)=5.41,P<0.05)。UC组织中TFPI的阳性率也显著高于正常结肠组织(43% 对17%,χ(2)=5.08,P<0.05)。

结论

UC中TF和TFPI的阳性表达率显著高于正常结肠组织。TF和TFPI可能在UC的发病机制中起重要作用。

相似文献

1
Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis.
World J Gastroenterol. 2014 Jun 21;20(23):7461. doi: 10.3748/wjg.v20.i23.7461.
2
Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.
World J Gastroenterol. 2013 Jun 7;19(21):3272-80. doi: 10.3748/wjg.v19.i21.3272.
3
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Ups J Med Sci. 2019 Nov;124(4):238-245. doi: 10.1080/03009734.2019.1689209. Epub 2019 Nov 27.
4
Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Nephrol Dial Transplant. 2006 Dec;21(12):3450-7. doi: 10.1093/ndt/gfl365. Epub 2006 Sep 17.
5
Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
World J Gastroenterol. 2013 May 7;19(17):2638-49. doi: 10.3748/wjg.v19.i17.2638.
6
Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis.
Dig Dis Sci. 2024 Oct;69(10):3773-3785. doi: 10.1007/s10620-024-08640-1. Epub 2024 Sep 25.
7
Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
Dig Dis Sci. 2017 Oct;62(10):2768-2779. doi: 10.1007/s10620-017-4662-3. Epub 2017 Jun 30.
10
Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
World J Gastroenterol. 2013;19(14):2234-41. doi: 10.3748/wjg.v19.i14.2234.

引用本文的文献

1
Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence.
Adv Exp Med Biol. 2023;1408:25-47. doi: 10.1007/978-3-031-26163-3_2.
2
Levels of TAFI, TFPI and ADAMTS-13 in inflammatory bowel disease.
Turk J Gastroenterol. 2019 Dec;30(12):1025-1029. doi: 10.5152/tjg.2019.19346.
3
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Ups J Med Sci. 2019 Nov;124(4):238-245. doi: 10.1080/03009734.2019.1689209. Epub 2019 Nov 27.

本文引用的文献

1
Alternatively spliced tissue factor - one cut too many?
Thromb Haemost. 2007 Jan;97(1):5-8. doi: 10.1160/th06-11-0670.
3
Platelets and anticoagulant capacity in patients with inflammatory bowel disease.
Pathophysiol Haemost Thromb. 2002 Mar-Apr;32(2):92-6. doi: 10.1159/000065082.
4
Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels.
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):218-24. doi: 10.1161/hq0102.101842.
9
Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.
Crit Care Med. 2000 Sep;28(9 Suppl):S31-3. doi: 10.1097/00003246-200009001-00007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验